Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients)

被引:43
|
作者
Pernot, M
Luporsi, E
Hoffstetter, S
Peiffert, D
Aletti, P
Marchal, C
Kozminski, P
Noel, A
Bey, P
机构
[1] CTR ALEXIS VAUTRIN,DEPT RADIAT THERAPY,F-54500 VANDOEUVRE NANCY,FRANCE
[2] CTR ALEXIS VAUTRIN,DEPT BIOSTAT,F-54500 VANDOEUVRE NANCY,FRANCE
[3] CTR ALEXIS VAUTRIN,DEPT HEAD & NECK TUMOURS,F-54500 VANDOEUVRE NANCY,FRANCE
[4] CTR ALEXIS VAUTRIN,DEPT RADIAT PHYS,F-54500 VANDOEUVRE NANCY,FRANCE
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 37卷 / 03期
关键词
radiotherapy; brachytherapy; oral cavity; oropharynx; complications; recording system;
D O I
10.1016/S0360-3016(96)00612-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study the rate and severity of complications in a series of 1134 patients treated by definitive irradiation for tumors of the oral cavity (772 cases) or the oropharynx (361 cases). Methods and Materials: Patients were staged as 29.5% T1, 42% T2, 26% T3, 2.5% T4-Tx, and 74.5% N0 tumors. We treated 364 patients with brachytherapy only (Ir-192) for the primary lesion. External irradiation and brachytherapy were combined for 770 patients. Results: The results included local control and survival. Out of 1134 patients, 330 had 376 complications. Grade 1 complications occurred in 20% of the patients, Grade 2 in 9%; Grade 3 in 4%; and Grade 4 in 0.2%. Of the Grade 1 complications, 78% were soft tissue and only 24% were bone complications. For the more severe grades (2, 3, and 4), there were 56 soft tissue complications and 90 bone complications out of 1340 patients. The statistical analysis included tumor-related factors and treatment-related factors. For the first two factors, only tumor location was significant. The treatment-related factors significant for complications were studied in univariate and multivariate study. This multivariate study confirmed that for soft tissue complications dose rate and volume treated were important (p < 0.001). It also confirmed that for bone complications, total dose >80 Gy, dose rate >0.7 Gy/h, and the absence of leaded protection of the mandible were all important factors. Conclusion: This statistical study should allow future reduction of severe complications (Grades 2, 3, 4), if treatment factors inducing them can be taken into account. This is not always possible for very large tumors. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [1] Management of cancers of the oral cavity and oropharynx
    Vikram, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 116 - 116
  • [2] CANCERS OF THE ORAL CAVITY AND OROPHARYNX - ADVANCES IN THERAPY
    BERTRAND, JC
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 1040 - 1041
  • [3] CANCERS OF THE ORAL CAVITY AND OROPHARYNX - ECONOMIC COST
    NIZRI, D
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 1042 - 1043
  • [4] RADIATION THERAPY IN MANAGEMENT OF CANCERS OF ORAL CAVITY AND OROPHARYNX
    JACOBSSO.F
    ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1964, 002 (06): : 476 - &
  • [5] Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers
    Moon, Dominic H.
    Moon, Sung Ho
    Wang, Kyle
    Weissler, Mark C.
    Hackman, Trevor G.
    Zanation, Adam M.
    Thorp, Brian D.
    Patel, Samip N.
    Zevallos, Jose P.
    Marks, Lawrence B.
    Chera, Bhishamjit S.
    ORAL ONCOLOGY, 2017, 72 : 98 - 103
  • [6] A Tale of Two Cancers: Carcinomas of the Oral Cavity and Oropharynx Preface
    Myers, Jeffrey N.
    Sturgis, Erich M.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2013, 46 (04) : XIII - XVI
  • [7] COMBINED MODALITY TREATMENT OF ADVANCED CANCERS OF THE ORAL CAVITY AND OROPHARYNX
    DOBROWSKY, W
    DOBROWSKY, E
    STRASSL, H
    BRAUN, O
    GRITZMANN, N
    SCHEIBER, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (02): : 239 - 242
  • [8] Outcome in oropharynx and oral cavity tumors following IMRT
    Studer, G.
    Graetz, K. W.
    Huber, G.
    Glanzmann, C.
    ORAL ONCOLOGY, 2009, : 63 - 63
  • [9] OSTEONECROSIS IN PATIENTS TREATED WITH DEFINITIVE RADIOTHERAPY FOR SQUAMOUS-CELL CARCINOMAS OF ORAL CAVITY AND NASOPHARYNX AND OROPHARYNX
    BEDWINEK, JM
    SHUKOVSKY, LJ
    FLETCHER, GH
    DALEY, TE
    RADIOLOGY, 1976, 119 (03) : 665 - 667
  • [10] Inequalities in overall survival of oropharynx, oral cavity, and larynx cancers in Brazil
    Menezes, F. S.
    de Oliveira, A. M. B.
    Toporcov, T. N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30 : V653 - V653